卒中领域的全球盛会——国际卒中大会（ISC2026）将于2月4日-6日在美国新奥尔良举行。每年的ISC大会上，都会公布本年度最受期待的临床试验的突破及发现。今年，多位中国专家将在会议上带来以TNK-PLUS、LAIS、OPTION、ATTENTION ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...

More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...